MX2011008512A - Productos que comprenden amidas de n-fenilpropenoil amino acido y usos de los mismos. - Google Patents

Productos que comprenden amidas de n-fenilpropenoil amino acido y usos de los mismos.

Info

Publication number
MX2011008512A
MX2011008512A MX2011008512A MX2011008512A MX2011008512A MX 2011008512 A MX2011008512 A MX 2011008512A MX 2011008512 A MX2011008512 A MX 2011008512A MX 2011008512 A MX2011008512 A MX 2011008512A MX 2011008512 A MX2011008512 A MX 2011008512A
Authority
MX
Mexico
Prior art keywords
products
amino acid
acid amides
phenylpropenoyl amino
phenylpropenoyl
Prior art date
Application number
MX2011008512A
Other languages
English (en)
Inventor
Karin Kraehenbuehl
Fabien Robert
Denis Marcel Barron
Jane Durga
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011008512A publication Critical patent/MX2011008512A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/10—Treating roasted coffee; Preparations produced thereby
    • A23F5/14—Treating roasted coffee; Preparations produced thereby using additives, e.g. milk, sugar; Coating, e.g. for preserving
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Cocoa products, e.g. chocolate; Substitutes therefor making liquid products, e.g. for making chocolate milk drinks and the products for their preparation, pastes for spreading, milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)

Abstract

La presente invención se refiere al uso de una composición que comprende amidas de N-fenilpropenoil amino ácido para la preparación de un producto para tratar o prevenir padecimientos neurodegenerativos, deterioro cognitivo, deterioro cognitivo moderado, demencia, alteraciones del estado de ánimo, depresión, trastornos del sueño, enfermedades que involucran agregación de proteína en un ser humano o en un animal, enfermedad de Alzheimer, degeneración macular o diabetes. La invención se refiere además a productos que comprenden amidas de N-fenilpropenoil amino ácido, que incluyen productos alimenticios y para beber, complementos alimenticios, y productos alimenticios para mascotas, y métodos para afectar el desempeño cognitivo de seres humanos y animales.
MX2011008512A 2009-02-13 2010-02-03 Productos que comprenden amidas de n-fenilpropenoil amino acido y usos de los mismos. MX2011008512A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09152775 2009-02-13
PCT/EP2010/051263 WO2010091981A2 (en) 2009-02-13 2010-02-03 Products comprising n-phenylpropenoyl amino acid amides and uses thereof

Publications (1)

Publication Number Publication Date
MX2011008512A true MX2011008512A (es) 2011-09-08

Family

ID=40800459

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008512A MX2011008512A (es) 2009-02-13 2010-02-03 Productos que comprenden amidas de n-fenilpropenoil amino acido y usos de los mismos.

Country Status (14)

Country Link
US (1) US20110313014A1 (es)
EP (1) EP2396083A2 (es)
JP (1) JP2012517970A (es)
KR (1) KR20110127204A (es)
CN (1) CN102405079A (es)
AU (1) AU2010212997A1 (es)
BR (1) BRPI1008427A2 (es)
CA (1) CA2752249A1 (es)
CL (1) CL2011001980A1 (es)
CO (1) CO6420320A2 (es)
MX (1) MX2011008512A (es)
RU (1) RU2011137563A (es)
WO (1) WO2010091981A2 (es)
ZA (1) ZA201106665B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666365A1 (en) * 2012-05-22 2013-11-27 Taminco Treatment of poultry, pigs or fish for reducing the feed conversion ratio.
CA2983091A1 (en) 2015-05-11 2016-11-17 Meiji Co., Ltd. Composition for facilitating production of brain-derived neurotrophic factor
KR20170001011U (ko) 2015-09-09 2017-03-17 오병서 조사각 조절이 용이한 터널등기구
CN105168456A (zh) * 2015-09-16 2015-12-23 韩志强 一种安乐片
US10040551B2 (en) * 2015-12-22 2018-08-07 International Business Machines Corporation Drone delivery of coffee based on a cognitive state of an individual
US10588885B2 (en) * 2016-07-12 2020-03-17 Vidya Herbs, Inc. Chlorogenic acid composition and method for its use in the treatment of Alzheimer's disease
CN106349099B (zh) * 2016-07-29 2018-08-07 西安科技大学 咖啡酸-赖氨酸及其衍生物、制备方法和用途
CN106242987B (zh) * 2016-07-29 2019-02-22 西安科技大学 一种防治糖尿病和糖尿病肾病药物及其合成方法和应用
US10952985B2 (en) 2017-10-12 2021-03-23 Vidya Herbs, Inc. Chlorogenic acid composition for the treatment of metabolic disorders
EA036612B1 (ru) * 2018-01-19 2020-11-30 Торегельды Шарманович ШАРМАНОВ Состав для производства шоколада из кобыльего молока
CN108484431A (zh) * 2018-03-26 2018-09-04 中国药科大学 一种肉桂酰氨基酸类化合物及其用途
JP2021014414A (ja) * 2019-07-10 2021-02-12 味の素株式会社 尿酸値低減作用を有する組成物の製造方法及び医薬品
WO2021028106A2 (en) * 2019-08-15 2021-02-18 Firmenich Sa Taste-modifying compounds and uses thereof
US11896600B2 (en) 2019-09-21 2024-02-13 Vidya Herbs, Inc. Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders
CN113444015B (zh) * 2020-03-24 2022-11-08 中国药科大学 一种肉桂酰氨基酸类化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379666B1 (en) * 1999-02-24 2002-04-30 Edward L. Tobinick TNF inhibitors for the treatment of neurological, retinal and muscular disorders
WO2002092068A1 (fr) * 2001-05-10 2002-11-21 Ono Pharmaceutical Co., Ltd. Derives d'acide carboxylique et medicaments contenant ces derives comme principe actif
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
DE102006033321A1 (de) * 2006-07-17 2008-01-24 Westfälische Wilhelms-Universität Münster Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
US8124802B2 (en) * 2007-01-26 2012-02-28 Jenrin Discovery, Inc. MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

Also Published As

Publication number Publication date
RU2011137563A (ru) 2013-03-20
WO2010091981A3 (en) 2010-10-28
KR20110127204A (ko) 2011-11-24
CA2752249A1 (en) 2010-08-19
EP2396083A2 (en) 2011-12-21
CO6420320A2 (es) 2012-04-16
ZA201106665B (en) 2013-02-27
JP2012517970A (ja) 2012-08-09
US20110313014A1 (en) 2011-12-22
AU2010212997A1 (en) 2011-09-08
WO2010091981A2 (en) 2010-08-19
CN102405079A (zh) 2012-04-04
BRPI1008427A2 (pt) 2016-03-01
CL2011001980A1 (es) 2012-04-20

Similar Documents

Publication Publication Date Title
MX2011008512A (es) Productos que comprenden amidas de n-fenilpropenoil amino acido y usos de los mismos.
PH12020500169A1 (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
MY151018A (en) Use of nutritional compositions for preventing disorders
WO2006074089A3 (en) Methods for enhancing the quality of life of a senior animal
MY173699A (en) Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins
JP2011511620A (ja) アミノ酸及びペプチド製品
MY182593A (en) Composition containing chitin and digestible proteins
MY169265A (en) Obesity animal model and methods for making and using thereof
RU2009108655A (ru) Производные лигустилида для лечения расстройств центральной нервной системы
WO2015006287A3 (en) Compositions prepared from poultry and methods of their use
WO2008071790A3 (en) Novel compositions and uses thereof
WO2007035722A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
WO2006013427A3 (en) Treatment of ccr2 mediated diseases or disorders
Joshi et al. Indian cow and A2 beta-casein–A scientific perspective on health benefits
TW200633645A (en) Increase in the protein proportion of animal organisms
JP2009507510A5 (es)
JPWO2016133157A1 (ja) リパーゼ阻害剤
WO2011012240A3 (de) Lipopeptide zur therapie und prophylaxe allergischer erkrankungen
Hidayah et al. The Potential of Bioactive Peptides from Animal Protein Sources as a Mental Health Problems Prevention
TW200740825A (en) Cripowellins and synthetic derivatives thereof as medicaments
CN102793166A (zh) 一种保健食品
WO2012121613A3 (en) Meat hydrolysates for food flavoring and medicaments
EP2670421A2 (en) Use of icam-1 for prevention or treatment of neurological diseases
WO2007009699A3 (en) Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal